Thera4Care was born out of a shared vision to transform cancer treatment through the power of radiotheranostics - a field that combines precise diagnostic imaging with targeted therapy. Recognising the limitations in conventional cancer treatments, Thera4Care was established by a team of leading scientists, healthcare professionals, and industry experts across Europe. Together, we aim to bridge the gap between innovative science and clinical practice, making personalised cancer care accessible to patients. With a commitment to advancing healthcare, Thera4Care seeks to bring new hope to those battling challenging cancers by focusing on precision, safety, and patient-centred solutions.
Thera4Care represents a diverse and dynamic alliance of 29 partners dedicated to pioneering advancements in healthcare. Coordinated by the Università Cattolica del Sacro Cuore in Rome, Policlinico Universitario Fondazione Agostino Gemelli, GE Healthcare, and Essen University Hospital, our consortium blends the expertise of universities, research institutions, industry, public bodies, non-profit groups, and small to medium-sized enterprises.
Company Details
- Employees
- 1
- Founded
- -
- Address
- The Growing Global Cancer Burden
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.thera4care.eu
- Keywords
- Brussels.
Thera4care Questions
Thera4Care's website is http://www.thera4care.eu
Thera4Care's LinkedIn profile is https://www.linkedin.com/company/thera4care
Thera4Care has
1 employees.
View email and phone details for 1
employees at Thera4Care.
Thera4Care's industry is
Biotechnology Research
Thera4Care's top competitors are
Ihi-Synthia,
Oncidium Foundation,
Innovative Health Initiative (Ihi),
Dosisoft,
European Association Of Nuclear Medicine (Eanm),
Predictom - Ihi Project,
Sck Cen,
Aiforia Technologies,
Accelerate.eu,
Ge Healthcare.
Thera4Care's categories are Biotechnology Research
Thera4Care's founding year is 2024
